πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12365664

Small molecule inhibitors of SRC tyrosine kinase

The Board of Regents of the University of Texas System Β· Granted Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12358909

Capsazepine analogs for the treatment of cancer and other proliferative diseases

The Board of Regents of the University of Texas System Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12359219

Transgene cassettes designed to express a human MECP2 gene

The Board of Regents of the University of Texas System Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12359204

Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and

The Board of Regents of the University of Texas System Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12357682

DNA plasmid-launched live-attanuated vaccines for plus-sense singel stranded RNA

The Board of Regents of the University of Texas System Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12357659

Production of megakaryocytes or platelets from monocytes

The Board of Regents of the University of Texas System Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12357580

Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids

The Board of Regents of the University of Texas System Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12351609

Use of a small native peptide activator of SERCA pump for treatment of heart failure and o

The Board of Regents of the University of Texas System Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12351877

Systems and methods for determining a treatment course of action

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12351560

Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12343424

Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreens

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12343388

Clostridioides difficile TcdB variants, vaccines and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12337017

Microbiota transfer therapy for Pitt Hopkins Syndrome

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12336982

Compositions and methods of modulating short-chain dehydrogenase activity

The Board of Regents of the University of Texas System Β· Granted Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12338459

DNA-chimeric antigen receptor T cells for immunotherapy

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12336976

Glutaminase inhibitor therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12329747

Use of lipophilic beta-lactam antibiotics and carboxylate esters for the treatment of bact

Board of Regents of the Nevada System of Higher Education on behalf of Nevada State College Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12331307

Modified immunization vectors

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12329744

Methods of preparing extrudates

The Board of Regents of the University of Texas System Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12329780

Acute and chronic mitochondrial electron transport chain dysfunction treatments and graphe

The Board of Regents of the University of Texas System Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12329756

Regulation of eIF4E activity for migraine therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12331110

Monoclonal antibodies against endotrophin and the use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12331130

DDR1 antibodies and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12331079

Oncolytic virus platform to treat cancers with myxoma virus

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted